A carregar...
Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention
Treatment of schizophrenia (SCZ) historically relies on the use of antipsychotic drugs to treat psychosis, with all of the currently available antipsychotics acting through the antagonism of dopamine D2 receptors. Although antipsychotics reduce psychotic symptoms in many patients, they induce numero...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8123139/ https://ncbi.nlm.nih.gov/pubmed/33922888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22094467 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|